Related Experiment Video
Updated: Aug 5, 2026

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
Two-year abrocitinib in atopic dermatitis: Are we reaching the new targets?
Axel De Greef1,2, Marie Baeck1,2
1Department of Dermatology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Abstract
No abstract available in PubMed .